Novo Nordisk’s Controlling Shareholder Plans To Invest About $7 Billion a Year By 2030

Novo Nordisk’s Controlling Shareholder Plans To Invest About $7 Billion a Year By 2030

Novo Holdings, the controlling shareholder of Novo Nordisk, a prominent Danish pharmaceutical company known for its focus on obesity and…

Read More »